​ ​

DAY 2: 1 May 2026

07:30 AM - 08:00 AM - Registration & Breakfast

08:00 AM - 09:30 AM RENAL TRANSPLANTATION (1)

• Kidney Transplantation in Qatar: Data, Directions, and Disparities
  [Essa Abuhalaiqa (QAT)]
• Biomarkers and Predictive Models in KidneyTransplantation
  [Alexandre Loupy (France)]
• Antibody-Mediated Rejection: New Prospects and Potential Therapies
  [Lionel Couzi (FRA)]
  
  

09:30 AM - 10:00 AM – Coffee Break

10:00 AM - 11:30 AM RENAL TRANSPLANTATION (2)

• Transplantation in the Highly Sensitized: Strategies for Success
  [Tomas Lorant (SE)]
• The Evolving Role of Crossmatch Techniques
  [Dr Medhat Askar (Qat)]
• Immuno-Tolerance: New Era of Immunosuppression-Free Transplantation
  [Alexandre Loupy (France)]
  
  

11:30 AM – 01:00 PM – Prayer and Lunch Break

01:00 PM - 03:00 PM GLOMERULAR DISEASES & VASCULITIS (1)

• Navigating New Treatment Horizons in IgA Nephropathy 
  [Jonathan Barratt (UK)] Virtual] 
• Thrombotic Microangiopathies: From Diagnosis to Individualized Management
  [Anuja Java (USA)]
• Targeted Therapy in ANCA-Associated Vasculitis: What’s New and What Works
  [David Jayne (UK)]
• From PLA2R to Beyond: Uncovering New Antigens in Membranous Nephropathy 
  [Sanjeev Sethi (USA) Virtual] 
  
  

03:00 PM - 03:30 PM – Prayer & Coffee break

03:30 PM - 04:30 PM GLOMERULAR DISEASES & VASCULITIS (2)

• Personalized Management in Lupus Nephritis
  [David Jayne (UK)]
• Complement and Beyond: C3GN and ICGN in the Era of Precision Medicine
  [Anuja Java (USA)]

04:30 PM - 06:00 PM PARALLEL WORKSHOPS

• Nephro-Pathology in Practice: Interactive Microscopy and Diagnostic Pearls
  [Turki Al-Hussain (KSA)]
• PD Unleashed: Advanced Techniques and Troubleshooting– Hands-on Session 
  [Edwina Brown (UK)]
  
  

06:00 PM - 06:30 PM – Prayer & Coffee Break

06:30 PM - 08:00 PM PREGNANCY AND KIDNEY DISEASE

• Hypertension and Preeclampsia: Risk Stratification, Management and Future Health
  [Kate Bramham (UK)]
• Pregnancy in Patients with Lupus Nephritis: Planning Across the Spectrum
  [Samar Al-Emadi (QAT)]
• Personalized Strategies for Safe Outcomes for all Kidney Disease Severities and Etiology
  [Kate Bramham (UK)]
  
  

08:00 PM - Dinner